Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LSTAthis companyLisata Therapeutics, Inc.	$1.09	-0.97×	1.09×	95.05×	-0.01×	89.2%	14.1%	-10711.2%	-9756.5%	-111.7%	-117.3%	-98.9%	0×	0.92×	0×	5.76×	0.0%	1	-74.76	2	C
MTVAMetaVia Inc.	$1.67	-1.15×	2.79×	0×	-0.37×	340.1%	0.0%	0.0%	0.0%	-243.3%	-21.6%	-105.6%	0.04×	0.78×	0×	1.93×	0.0%	0	-18.95	3	B
PASGPassage Bio, Inc.	$3.95	-0.82×	2×	0×	-0.34×	101.7%	0.0%	0.0%	0.0%	-242.7%	-100.9%	-84.2%	1.28×	0.5×	0×	2.07×	0.0%	1	-43.91	2	C
PTHSPelthos Therapeutics Inc.	$9.30	-1.35×	1.5×	3.47×	-1.65×	872.0%	44.2%	-193.1%	-257.9%	-111.4%	-26.4%	-38.9%	0.9×	-0.37×	-10.77×	2.03×	0.0%	4	-2.04	2	B-
XCURExicure, Inc.	$0.89	-6.86×	8.69×	0×	-5.97×	-65.3%	0.0%	0.0%	0.0%	-126.0%	-86.8%	-25.1%	0.04×	0.7×	-10,117×	1.19×	0.0%	1	-27.84	1	C-
Peer median	—	-1.25×	2.39×	0×	-1.01×	220.9%	0.0%	0.0%	0.0%	-184.3%	-56.6%	-61.5%	0.47×	0.6×	-5.38×	1.98×	0.0%	1	-23.39	2	—